MedPath
FDA Approval

Levonorgestrel

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 15, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Levonorgestrel(0.75 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levonorgestrel

Product Details

NDC Product Code
68180-851
Application Number
ANDA091328
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 15, 2019
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
Code: 5W7SIA7YZWClass: ACTIBQuantity: 0.75 mg in 1 1
POVIDONEInactive
Code: FZ989GH94EClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath